Do you need IV antibiotics for MRSA?
MRSA is treatable. By definition, MRSA is resistant to some antibiotics. But other kinds of antibiotics still work. If you have a severe infection, or MRSA in the bloodstream, you will need intravenous antibiotics.
What IV antibiotics treat staphylococcus aureus?
Cost of Antibiotic Therapy for Staphylococcus aureus Infections
| Antibiotic | Representative dose |
|---|---|
| Nafcillin | 2 g intravenously every four hours |
| Cefazolin (Ancef) | 2 g intravenously every eight hours |
| Vancomycin (Vancocin) | 1 g intravenously every 12 hours |
| Daptomycin (Cubicin) | 300 mg intravenously once daily |
How long do you need IV antibiotics for MRSA?
Treatment options for health care–associated MRSA or community-associated MRSA pneumonia include seven to 21 days of intravenous vancomycin or linezolid, or clindamycin (600 mg orally or intravenously three times per day) if the strain is susceptible.
How long is IV treatment for MRSA?
Can a sequential IV to oral treatment be used for MRSA?
Sequential iv-to-oral antibiotic therapy has been successfully applied to other serious infections but has not been evaluated for MRSA BSI.
What kind of antibiotics can you take for MRSA?
IV antibiotics. A number of IV antibiotics can effectively treat MRSA infections, including the following: First-line therapy: vancomycin. Appropriate dosage is 30 mg/kg, but the dose should not exceed 2 g in any 24-hour period.
When to use empiric therapy for MRSA infection?
For hospitalized patients with complicated skin and soft-tissue infections (i.e., deeper soft-tissue infections, surgical or traumatic wound infection, major abscesses, cellulitis, or infected ulcers and burns), empiric therapy for MRSA should be considered pending culture results, in addition to surgical debridement and broad-spectrum antibiotics.
Which is the fifth line treatment for MRSA?
Fifth-line therapy: quinupristin/dalfopristin (Synercid). In addition to the antibiotics listed above, a number of emerging therapies may be useful for the treatment of MRSA, including dalbavancin, telavancin (Vibativ, Theravance), and ceftobiprole.